SEC Form 4 · accession 0001209191-16-128869
Viridian Therapeutics, Inc.\DE · VRDN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Smith
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 20, 2016 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590750
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.51 | Jun 15, 2016 | A | 18,000 | A | — | Jun 15, 2026 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The option shall vest and become exercisable in twelve equal monthly installments beginning on June 30, 2016 and ending on May 31, 2017.